Study of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive
Clinical trial NCT03992170 · UNKNOWN
Trial details
- NCT number
- NCT03992170
- Sponsor
- Azienda Ospedaliera Universitaria Senese
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-31
- Primary completion
- 2022-06-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.